{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:30:16Z","timestamp":1759624216268,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejogrb.2021.01.012","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T07:43:58Z","timestamp":1610523838000},"page":"273-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Do oral ovulation induction agents offer benefits in women 38 to 43 years of age undergoing insemination cycles?"],"prefix":"10.1016","volume":"258","author":[{"given":"Naama","family":"Steiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Ruiter-Ligeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-4888","authenticated-orcid":false,"given":"Russell","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Al Shatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Badeghiesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Rotshenker-Olshinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Buckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2021.01.012_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0974-1208.74152","article-title":"Fertility and age","volume":"3","author":"George","year":"2010","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0010","unstructured":"Female Age-Related Fertility Decline. Committee Opinion No. 589 - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/24559617-female-age-related-fertility-decline-committee-opinion-no-589\/?from_single_result=Committee+Opinion+No.+589+Fertility+and+Sterility%2C+2014 (Accessed February 13, 2020)."},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7827-8-21","article-title":"Management of the infertile couple: an evidence-based protocol","volume":"8","author":"Kamel","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.rbmo.2019.05.023","article-title":"The management of unexplained infertility: an evidence-based guideline from the Canadian Fertility and Andrology Society","volume":"39","author":"Buckett","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005356.pub2","article-title":"Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists\/antagonists) for intrauterine insemination (IUI) in women with subfertility","author":"Cantineau","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0030","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0035","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/oxfordjournals.humrep.a138385","article-title":"Infertility: predicting and optimizing success in an intra-uterine insemination programme","volume":"9","author":"Plosker","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0040","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/oxfordjournals.humrep.a138438","article-title":"Infertility: is there a role for ovarian stimulation and intra-uterine insemination after age 40?","volume":"9","author":"Frederick","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.fertnstert.2009.02.040","article-title":"Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women","volume":"94","author":"Harris","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0050","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.fertnstert.2007.10.057","article-title":"Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles","volume":"90","author":"Dovey","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0055","unstructured":"Sahakyan M., Harlow B.L., Hornstein M.D. Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination. n.d."},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1933719116667215","article-title":"In vitro fertilization versus mild stimulation intrauterine insemination in women aged 40 and older","volume":"24","author":"Nemer","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0065","first-page":"305","article-title":"Evidence-based treatments for couples with unexplained infertility: a guideline","volume":"113","author":"Committee of the American Society for Reproductive Medicine P","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2021.01.012_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.03.012","article-title":"A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and over Treatment Trial (FORT-T)","volume":"101","author":"Goldman","year":"2014","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:52:45Z","timestamp":1759557165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":14,"alternative-id":["S0301211521000245"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.01.012","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do oral ovulation induction agents offer benefits in women 38 to 43 years of age undergoing insemination cycles?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}